Positive association of the β fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction

Thrombosis and Haemostasis

Volumn 77, Issue 6, 1997, Pages 1120-1126

  Gardemann, Andreas ^a   Schwartz, Oliver ^a   Haberbosch, Werner ^a   Katz, Norbert ^a   Weiß, Tanja ^a   Tillmanns, Harald ^a   Hehrlein, Friedrich Wilhelm ^a   Waas, Wolfgang ^a   Eberbach, Andreas ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN;

ACUTE PHASE RESPONSE; ADULT; AGED; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; FIBRINOGEN BLOOD LEVEL; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HIGH RISK POPULATION; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR;

EID: 0030845155     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1656123     Document Type: Article

References (32)

1. Meade TW, Mellows S. Brozovic M et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 336: 533-7.
2. Lee AJ, Lowe GDO, Woodward M, Tunstall-Pedoe H. Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study. Br Heart J 1993; 69: 338-42.
3. ECAT Angina Pectoris Study Group. ECAT angina pectoris study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography. Eur Heart J 1993: 14: 8-17.
4. Wilhelmsen L Svärdsudd K. Korsan-Bengtsen K. Larsson B. Welin L, Tibbliu G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-5.
5. Yarnell JW, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, Elwood PC. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischaemic heart disease. Circulation 1991; 83: 836-44.
6. Kannel WB, Wolf PA Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease: the Framingham study. JAMA 1987; 258: 1183-6.
7. Ernst E. Resch KL. Fibrinogen as a cardiovascular risk factor a meta-analysis and review of the literature. Ann Intern Med 1993 1993; 118: 956-63.
8. Fey GH, Fuller GM. Regulation of acute phase gene expression by inflammatory mediators. Mol Biol Med 1987; 4: 323-38.
9. Balleisen L, Bailey J, Epping PH, Schulte H, van de Loo J. Epidemiology study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body weight, smoking, alcohol, pill using and menopause. Thromb Haemost 1985; 54: 475-9.
10. Folsom AR. Epidemiology of fibrinogen. Eur Heart J 1995; 16 (Suppl A): 21-4.
11. Fuller JH, Keen H, Jarrett RJ, Omer T, Meade TW, Chakrabarti R, North WRS, Stirling Y. Haemostatic variables associated with diabetes and its complication. Br Med J 1979; 2: 964-966.
12. Abbot RD, Yin Yin MA, Ree DM, Yano K. Risk of stroke in male cigarette smokers. N Engl J Med 1986; 315: 717-20.
13. Lee AJ, Smith WCS, Lowe GDO, Tunstall-Pedoe H. Plasma fibrinogen and coronary risk factors: The Scottish heart health Study. J Clin Epidemiol 1990; 43: 913-9.
14. Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlic PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991; 91: 191-205.
15. Roy SM, Mukhopadtyay G, Redman CM. Regulation of fibrinogen assembly. Transfection of HepG2 cells with Bβ cDNA specifically enhances synthesis of the three component chains of fibrinogen. J Biol Chem 1990; 265: 6389-93.
16. Thomas AE, Green FR, Kelleher CH, Wilkes HC, Brennan PJ, Meade TW, Humphries SE. Variation in the promoter region of the β fibrinogen gene is associated with plasma fibrinogen levels in smokers and nonsmokers. Thromb Haemost 1991 ; 65: 487-90.
17. Green F, Hamsten A, Blombäck M, Humphries S. The role of β-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemost 1993; 70: 915-20.
18. Scarabin PY, Bara L, Ricard S, Poirier O, Cambou JP, Arveiler D, Luc G, Evans AE, Samama MM, Cambien F. Genetic variation at the β-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM study. Arterioscl Thromb 1993; 13: 886-91.
19. Behague I, Poirier O, Nicaud V, Evans A, Arveiler D, Luc G, Cambou JP, Scarabin PY, Bara L, Green F, Cambien F. β-Fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Circulation 1996; 93: 440-9.
20. Gardemann A, Schwartz O, Weiß T, Katz N, Eberbach A, Hehrlein W, Tillmanns G, Haberbosch W. Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme is associated to coronary artery disease and myocardial infarction in low risk patients. Circulation 1995; 92: 2796-9.
21. Gensini GG. Coronary arteriography. In: Heart disease. Braunwald E (ed). Philadelphia, WB Saunders Co, 1980: 352-3.
22. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51: 606.
23. Ernst E, Resch KL. Therapeutic interventions to lower plasma fibrinogen concentrations. Eur Heart J 1995; 16 (Supplement A): 47-53.
24. Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982; 82: 2077-80.
25. Kattermann R, Jaworek D, Moller G, Assmann G, Bjorkhem I, Svensson L, Borner K, Boerma G, Leijnse B, Desager JP. Multicenter study of a new enzymatic method of cholesterol determination. Clin Chem Clin Biochem 1984; 22: 245-51.
26. Fink PC, Romer M, Haeckel R, Fateh-Moghadam A, Delanghe J, Gressner AM, Dubs RW. Measurement of proteins with the Behring nephelometer. A multicenter evaluation. J Clin Chem Clin Biochem 1989; 27: 261.
27. Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol (Basel) 1957; 17: 237.
28. Ross DW, Brecher G, Bessis M. Automation in Hematology. Springer, Berlin, Heidelberg, New York 1981.
29. Kawasaki ES. Sample preparation from blood, cells, and other fluids. In: PCR protocols: A guide to methods and applications. Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds). Academic Press Inc. San Diego 1990; 146-52.
30. Sosef MN, Bosch JG, van Oostayen J, Visser T, Reiber JHC, Rosendaal FR. Relation of plasma coagulation factor VII and fibrinogen to carotid artery intima-media thickness. Thromb Haemost 1994; 72: 250-4.
31. Koster T, Rosendaal FR, Reitsma PH, van der Velden PA, Briet E, Vandenbroucke JP. Factor VII and fibrinogen levels as risk factors for venous thrombosis. Thromb Haemost 1994; 71: 719-22.
32. Yu S, Sher B, Kudryk B, Redmann CM. Intracellular assembly of human fibrinogen. J Biol Chem 1983; 258: 13407-10.